We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SCNLF market cap is 130.63M. The company's latest EPS is GBP -0.0057 and P/E is -16.14.
| Year End 30 April 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 5.27M | 0 |
| Operating Income | -6.78M | -8.83M | -13.3M | -11.56M | -18.26M |
| Net Income | -5.51M | -15.48M | -4.57M | -11.94M | -5.86M |
| Year End 30 April 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 8.82M | 49.06M | 38.52M | 26.86M | 23.58M |
| Total Liabilities | 1.17M | 29.57M | 33.71M | 36.5M | 27.08M |
| Total Equity | 7.65M | 19.49M | 4.81M | -9.65M | -3.51M |
| Year End 30 April 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -4.77M | -7.8M | -10.19M | -8.14M | -15.66M |
| Investing | -13k | -741k | -1.26M | 81k | 178k |
| Financing | 3.8M | 46.08M | -928k | -746k | 10.39M |
| Market Cap | 130.63M |
| Price to Earnings Ratio | -16.14 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.43 |
| Price to Book Ratio | -27.21 |
| Dividend Yield | - |
| Shares Outstanding | 1.04B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 5k |
| 52 Week Change | -0.79% |
| 52 Week High | 0.2335 |
| 52 Week Low | 0.1255 |
| Spread (Intraday) | 0.04 (30.18%) |
| Company Name | Scancell Holdings PLC (PK) |
| Address |
bellhouse building oxford OX4 4GD |
| Website | https://\www.scancell.co.uk |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
